David is Director of Business Development and R&D Communications at Ipsen Pharmaceuticals in Cambridge, MA. In this role he is responsible for full 360 degree communications, including external and internal. David has over twenty years experience in biotech and pharmaceutical communications, holding key leadership positions in global organizations. He has led external, product, crisis, change and digital communications for a number of organizations including Merck, Regeneron, Otsuka, Novartis and Takeda. David’s specific areas of expertise include translating complex scientific data and medical information for non-scientific audiences; steering organizational narrative, authoring and executing strategic communications and crisis communications plans; and external and digital communications. He has driven communications for product recalls and shortages, FDA mandated letters and natural disasters. He drove product communications for a $6 billion global brand. David is a graduate of Syracuse University’s Newhouse School of Public Communications. He lives with his family in Boxborough, Massachusetts.

Mary T. Conway, Principal of Conway Communications, brings extensive experience in investor relations and financial public relations. Prior to establishing the firm, she held senior positions at several Boston public relations firms, providing investor relations consulting and overseeing client service and new business development. Previously, she was a senior manager at Polaroid Corporation, handling executive communications and overseeing corporate and marketing public relations. Ms. Conway was a partner at Kekst and Company (now part of Publicis), the premier financial public relations firm in New York. There, Ms. Conway worked with domestic and international companies, legal counsel and investment bankers, on investor relations and corporate transactions ranging from mergers and acquisitions to initial public offerings, leveraged buyouts, divestitures, bankruptcies, proxy fights and reorganizations. She also managed crisis communications – for product recalls, personnel and operational issues, major litigation and other sensitive matters -- for clients. Ms. Conway holds an A.B. degree cum laude from Dartmouth College.

Ms. Devlin joined Vertex in 2019 as Senior Vice President and Chief Communications Officer. In this role, she is responsible for leading the global corporate communications function, spanning product communications, media relations, digital and social communications, internal communications, corporate social responsibility and community affairs. Ms. Devlin joined Vertex from the U.S. Food and Drug Administration (FDA), where she served as senior communications advisor to FDA Commissioner Scott Gottlieb. Prior to this, Ms. Devlin spent seven years as the Head of Global Communications for Mylan NV, one of the world’s largest generics and specialty pharmaceutical companies, overseeing external, financial, digital and internal communications, as well as the company’s corporate social responsibility program. Before Mylan, Ms. Devlin spent 15 years at leading global communications agencies, including Edelman and Brunswick Group. Ms. Devlin received her bachelor’s degree in international relations from Georgetown University’s School of Foreign Service.

Ms. Nicole Kopecky is the Director of Financial Reporting at Dicerna Pharmaceuticals, a clinical stage, biotechnology company in the RNAi space. She is responsible for SEC filings, technical accounting, accounting policies, taxes, and SOX compliance functions, and serves as an integral component in crafting all material public disclosures. She has over 15 years of experience in various accounting and financial reporting matters. Ms. Kopecky is a CPA who began her career at PricewaterhouseCoopers in the audit practice where she serviced clients across a broad range of industries.